日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oligomerization is required for channel formation of MctB and for copper resistance of Mycobacterium tuberculosis

寡聚化是MctB通道形成和结核分枝杆菌铜耐药性所必需的。

Siroy, Axel; Sun, Demeng; Paul, Avraneel; Rowland, Jennifer L; Jones, Lisa M; Prevelige, Peter; Tian, Changlin; Niederweis, Michael

Integrative genomic analysis identifies key target genes and candidate drugs for spinal stenosis

整合基因组分析可识别脊柱狭窄的关键靶基因和候选药物

Xia, Demeng; Chen, Yongjie; Wu, Rui; Tang, Yifan; Sun, Yanqing; Chen, Xiongsheng

Intra-strain and inter-strain heterogeneity shape phage-host interactions and phenotypic adaptation in Pseudomonas aeruginosa

铜绿假单胞菌的菌株内和菌株间异质性影响噬菌体-宿主相互作用和表型适应

Sui, Bingrui; Li, Xiaoyu; Wang, Lili; Xu, Yongping; Hou, Yumin; Khan, Muhammad Saleem Iqbal; Li, Na; Tan, Demeng

Phage-mediated horizontal transfer of Salmonella enterica virulence genes with regulatory feedback from the host

噬菌体介导的沙门氏菌毒力基因水平转移及其来自宿主的调控反馈

She, Tianjing; Tan, Demeng; Balcazar, Jose Luis; Friman, Ville-Petri; Wang, Danrui; Zhu, Dong; Ye, Mao; Sun, Mingming; Yuan, Shujian; Hu, Feng

Molecular mechanism of the arrestin-biased agonism of neurotensin receptor 1 by an intracellular allosteric modulator

细胞内变构调节剂介导的神经降压素受体1的阻遏蛋白偏向性激动作用的分子机制

Sun, Demeng; Li, Xiang; Yuan, Qingning; Wang, Yuanxia; Shi, Pan; Zhang, Huanhuan; Wang, Tao; Sun, Wenjing; Ling, Shenglong; Liu, Yuanchun; Lai, Jinglin; Xie, Wenqin; Yin, Wanchao; Liu, Lei; Xu, H Eric; Tian, Changlin

Neoadjuvant chemotherapy plus anlotinib in the treatment of resectable head and neck squamous cell carcinoma: A pilot phase II trial

新辅助化疗联合安罗替尼治疗可切除的头颈部鳞状细胞癌:一项 II 期试点试验

He, Qianting; Huang, Shuojin; Tang, Dongxiao; Cao, Congyuan; Zhou, Wanhang; Ling, Rongsong; Chen, Jie; Yun, Bokai; Zheng, Xin; Li, Yanchen; Wang, Anxun; Chen, Demeng

Plant essential oil targets TRPV3 for skin renewal and structural mechanism of action

植物精油通过靶向TRPV3促进皮肤更新和结构性作用。

Li, Yang; Lu, Xuteng; Cheng, Xufeng; Xia, Keyu; Hu, Junyan; Wang, Peiyu; Pang, Peiyuan; Gao, Bomin; Sun, Demeng; Zhang, Zhuzhen; Li, Dongdong; Deng, Zengqin; Tian, Changlin; Xie, Chang; Yao, Jing

Author Correction: Resistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils

作者更正:头颈癌中抗LAG-3联合抗PD-1疗法的耐药性是由Sox9+肿瘤细胞与Fpr1+中性粒细胞的相互作用介导的。

Wang, Xiaochen; Cheng, Maosheng; Chen, Shuang; Zhang, Caihua; Ling, Rongsong; Qiu, Shuqing; Chen, Ke; Zhou, Bin; Li, Qiuli; Lei, Wenbin; Chen, Demeng

Resistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils.

头颈癌对 LAG-3 抗 PD-1 疗法的耐药性是由 Sox9+ 肿瘤细胞与 Fpr1+ 中性粒细胞相互作用介导的

Wang Xiaochen, Cheng Maosheng, Chen Shuang, Zhang Caihua, Ling Rongsong, Qiu Shuqing, Chen Ke, Zhou Bin, Li Qiuli, Lei Wenbin, Chen Demeng

Tumor-initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice

在小鼠体内,肿瘤起始细胞通过肿瘤相关巨噬细胞释放的CCL8逃避免疫攻击。

Shuang Chen ,Chensong Huang ,Kang Li ,Maosheng Cheng ,Caihua Zhang ,Jianqi Xiong ,Guoli Tian ,Ruoxing Zhou ,Rongsong Ling ,Xiaochen Wang ,Gan Xiong ,Zhihui Zhang ,Jieyi Ma ,Yan Zhu ,Bin Zhou ,Liang Peng ,Zhenwei Peng ,Heping Li ,Demeng Chen